Guobang Pharma Ltd Sustainability Reports
Guobang Pharmaceutical Group Co., Ltd. is engaged in the research, development, production, and sale of pharmaceutical and veterinary active pharmaceutical ingredients (APIs) and formulations. The company specializes in manufacturing synthetic APIs, including bulk antibiotics like quinolones and macrolides.
Sector: Manufacturing
Country: China
Exchange: Shanghai Stock Exchange
FIGI: BBG001WPQF68
4 reports from 2022 to 2025
